Archive for the ‘Uncategorized’ Category

WSJ Says Chronic Lyme Was Once Dismissed But Doctors Are Coming Around – I Disagree

FILE_7701.pdf  Article Here

Chronic Lyme Disease Was Once Dismissed. More Doctors Are Coming Around.

Newer trials are starting to track Lyme patients and investigate potential treatments

By Brianna Abbott Jul 20, 2025

(See link above for article)

_____________

Why This Research Won’t Help Patients One Iota

By Alicia Cashman, Madison Lyme Support Group, Wisconsin

7/24/25

Summary of WSJ article:

  • A 63 year old Massachusetts woman was told in 2015 the root of her odd, flulike illness was likely Lyme disease.  (This website has hundreds if not thousands of such stories)
  • For the next decade she cycled through ‘unproven’ treatments and got push-back from doctors. (They must push the ‘not proven’ issue to keep us all from getting extended antibiotics which would make a majority of us better)
  • When MIT starting recruiting ‘people just like her,’ she felt validated.
  • The article then states ‘long COVID,’ is what is bringing chronic Lyme more credibility.
  • True to form and right on cue, long time player – Dr. John Aucott of Johns Hopkins, who has studied chronic Lyme for TWO decades but hasn’t budged the needle an inch, repeats the narrative that ‘long COVID’ has given chronic Lyme more ‘acceptance.’ (You must understand that there’s a lot of grant money for those who ignore the fact the COVID shots are likely behind ‘long COVID. It must also be stated that ‘long COVID’ looks exactly like other post-viral syndromes.) Vaccine injury gets ZERO grant money because our own government and researchers are beholden to Big Pharma. Vaccines are the cash cow of research.
    • The cat is let out of the bag on the final page of the article when it’s stated that the study includes acute Lyme and ‘long COVID’ participants.
      • First, notice that the reason we are hearing the clanging mantra of ‘long COVID’ is because it’s a part of the study. A lie can travel halfway around the world while the truth is putting on its shoes.
      • Second, notice that they are ONLY looking at ACUTE Lyme – something that’s been studied ad nauseam.  This research once again omits the sickest patients who never have any research done on them.
    • Thirdly, the cat continues to be let out when it’s stated they are looking for whether a molecule left behind could be driving inflammation Right there – they are admitting their bias that this is not a chronic, persistent infection that could be cured or benefitted with anti-microbial treatments.
  • The author is oblivious to the fact that Post-Treatment Lyme Disease Syndrome (prolonged symptoms for at least 6 months after treatment) doesn’t include a HUGE subset of patients who were diagnosed and treated late.  This continued regurgitated ignorance is allowing research to be skewed in favor of chronic Lyme only affecting 5-20% of patients – which is a much smaller deal than 40-60%, when those diagnosed and treated late are included.
  • The article repeats a falsehood: that in order to get Lyme one NEEDS to be bitten by a bacteria-carrying tick.  Congenital Lyme has been proven, and there is much to indicate  sexual transmition as well.
  • The reason they ignore anything but ticks is because then they can state their next falsehood, which fits the ‘climate changenarrative, which has been proven false by an independent tick researcher.
  • Third falsehood: a 2-4 week course of antibiotics cures the disease.
  • Fourth falsehood: blood tests can help determine if a person has antibodies against the pathogen. Seronegativity has been a big part of the Lyme debate from the beginning.
    • Part of the reason for this is the fact one of the most specific bands for Lyme was taken out of testing at the Dearborn, MI conference because it interfered with vaccine development.
    • Another reason is the fact that arbitrary levels of antibodies have been set, keeping a majority of those infected from ever testing positive.
    • Yet another reason is the fact that there has been a concerted suppression of microscopy  which is considered the gold standard for syphilis diagnostics. Similarly to the attacks on ivermectin and HCQ for COVID, ‘the powers that be’ continue to attack any test other than the CDC 2-tiered test for not being ‘FDA approved,’ even though the CDC test is not ‘approved’ either.
  • Fifth falsehood: there are no treatments that have been proven safe and effective after the initial antibiotics. My husband and I were in intense treatment for over 5 years using multiple antibiotics, among other things, simultaneously. Without this life-saving treatment I wouldn’t be writing this article today.
  • Proving that nobody’s coming around to accept Lyme Disease – read, “Gaslighting and Cults: Our Baffling Relationship With Tick-Borne Diseases,” written this past January, 2025.

This study won’t help chronically infected patients.  Don’t expect anything from this.  It’s the same crap, different day.  

For more:

Until we start OVER, and I mean from square one, research is all tainted and biased.  Don’t believe me?  Listen to Willy himself:

http://

Willy Burgforfer, Ph.D. Lyme Disease ‘Discoverer’

ACTION – Time Sensitive Appropriations Bill Provisions to Shield the Chemical Industry From Liability From Harms & Restricting EPA’s Ability to Protect the Public

https://childrenshealthdefense.org/community/tell-your-representative-remove-appropriations-bill-riders-protecting-industry-hurting-consumers

URGENT: Tell Your Representative: Remove Appropriations Bill Riders Protecting Industry, Hurting Consumers

It’s urgent that you act now to prevent granting liability protection to chemical companies, allowing them to harm consumers with no chance of being held accountable.

July 19, 2025

Take Action TODAYThe U.S. House of Representatives Appropriations Committee is scheduled to meet on Tuesday, July 22 to vote on the Appropriations Bill which contains extremely troubling provisions quietly added into the proposed legislation. These provisions are designed to shield the chemical industry from liability from harms to farmers and consumers while restricting the Environmental Protection Administration’s (EPA) ability to protect citizens from harmful exposures.

Section 453 was added to the bill to block the government from taking action on health concerns if they differ in any way from the EPA’s most recent health assessments, however outdated and inadequate they may be. The EPA and other agencies would be required to perform new assessments that could take four to 12 years even if new science shows harm and even if the original assessment was found to be based on fraud. If passed, Section 453 will strip farmers and consumers from their ability to seek damages against chemical manufacturers from injury and death when these companies fail to disclose potential harms occurring from exposure to their products.

Section 507 drastically reduces the EPA’s ability to protect consumers from PFAS (per- and polyfluoroalkyl substances), the manmade “forever chemicals” that have profound negative implications upon human health including cancer, hormone disruption, liver and thyroid problems, reproductive harm, and abnormal fetal development.

American citizens need more transparency and accountability – not less – as passage of the Appropriations Bill in its current state will ensure. Email your representative TODAY using the form in the above link. You can also call the committee members’ office to tell them to remove Sections 453 and 507 from the Bill. Phone numbers are below the form, and on the confirmation page you will see after submitting the form.

It’s urgent that you act now to prevent granting liability protection to chemical companies, allowing them to harm consumers with no chance of being held accountable.

Study: Sunlight Penetrates the Human Body, Improving Mitochondrial Function & Vision

https://www.thefocalpoints.com/p/new-study-sunlight-penetrates-the?

NEW STUDY: Sunlight Penetrates the Human Body, Improving Mitochondrial Function and Vision

Just 15 minutes of fully clothed infrared sunlight exposure triggered systemic effects and measurable improvements in vision — even with eyes completely covered.

A new study published in Scientific Reports titled, Longer wavelengths in sunlight pass through the human body and have a systemic impact which improves vision, confirms what animal studies have long suggested: longer wavelengths of sunlight—particularly in the infrared range (830–860 nm)—can penetrate the human body and improve mitochondrial function systemically. Remarkably, even 15 minutes of back exposure (fully clothed) improved vision 24 hours later — without any light entering the eyes.

40 adults (ages 25–63) participated in the study. Researchers first measured sunlight transmission by placing a radiometer against the chest of shirtless participants standing in direct midday sunlight. In a controlled lab setting, subjects were then exposed to 15 minutes of 850 nm near-infrared (NIR) LED light directed at their backs. Visual performance was evaluated before and 24 hours after exposure using color contrast sensitivity tests. To isolate systemic effects from direct eye exposure, a subgroup wore foil-wrapped head coverings to fully block light from reaching the eyes.

Key Findings

  • Sunlight penetrates the human torso. Infrared wavelengths (especially 850 nm) passed through the chest and back, reaching internal tissues. Peak transmission was observed between 800–875 nm.

  • Mitochondrial boost to visual function. A single 15-minute exposure to 850 nm light led to a 16% improvement in tritan (blue-yellow) contrast sensitivity and a 9% improvement in protan (red-green) sensitivity 24 hours later — even in dim lighting conditions.

  • Systemic effect confirmed. In participants whose heads were completely covered with foil (blocking all ocular exposure), tritan sensitivity still improved by 7%, proving that long-wavelength light acts systemically — likely via mitochondrial and cytokine signaling pathways.

  • Clothing is not a barrier. Even six layers of common garments (T-shirt, shirt, wool sweater) were nearly 100 times more transparent to 850 nm light than to visible light, allowing infrared to reach the skin and tissues underneath.

  • Built environment warning. Most indoor LED lighting lacks infrared and instead emits sharp peaks in the blue spectrum (400–450 nm), which are known to impair mitochondrial function and elevate oxidative stress, especially in the absence of balancing long wavelengths.

These findings underscore the critical role of full-spectrum sunlight — particularly its infrared components — in maintaining cellular health and sensory function. As modern environments increasingly rely on artificial lighting that omits these beneficial wavelengths, we are depriving our bodies of essential biological signals. Daily exposure to natural sunlight, even through clothing, appears to be a simple yet powerful tool to support mitochondrial health and optimize vision.


Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

_____________

For more:

First Peer-Reviewed Study Documents Post-Injection Magnetism

https://www.thefocalpoints.com/p/breaking-first-peer-reviewed-study?

BREAKING – First Peer-Reviewed Study Documents Post-Vaccine Magnetism

Magnetism appeared months after mRNA injection—Pfizer “F” lots were disproportionately linked, with proposed mechanisms involving spike-induced iron metabolism disruption.

The study titled, Clinical Manifestations of Iatrogenic Magnetism in Subjects After Receiving COVID-19 Injectables: Case Report Serieswas just published in the International Journal of Innovative Research in Medical Science:

Abstract

A series of cases of COVID-19 vaccine-injected patients suffering from iatrogenic magnetism is described. The attachment of massive metallic objects (up to 70 grams) to different parts of the body is a real phenomenon that may present additional health risks if such patients are subjected to magnetic resonance imaging (MRI). The iatrogenic magnetism phenomenon typically appears several months after the injection. More likely, injected DNA plasmids, or modified mRNAs, translated into the spike protein, or into junk peptides formed through frameshifts, may engender proteins with ferromagnetic properties, or may entrap endogenous iron. Importantly, the spike protein has a distant homology to hepcidin, the key regulator of iron metabolism. Redistribution of iron into the brain or other body parts may be causing iatrogenic magnetism. Pfizer vaccine lots starting with the letter “F” may be involved, although we cannot exclude the possibility that Moderna or other manufacturers’ injections may also cause this phenomenon. In our observation, the magnetism may resolve spontaneously or when nicotinamide adenine dinucleotide (NAD+) is applied. Our pilot observation needs to be corroborated in a larger cohort study.

(See link for article and pictures)

_______________

**Comment**

Chalk another one up to the ‘conspiracy theorists’ who continue to be proven right.

This magnetism is real and appears to be associated with Pfizer lots beginning with the letter ‘F’, although it was observed with the Moderna shot as well but less frequently.  Two cases were reduced or resolved with 500mg oral NAD+ per day.  Cases are discussed in the article.

Pfizer doesn’t mention the phenomenon and the study authors are calling for independent quality control testing, which frankly should always be done before a new drug or medical device is rolled out, and particularly if people are told they will lose their jobs if they don’t take it!

We just don’t know what’s in this stuff,” he said. “They’ve been very secretive,” he continued. ~ Dr. Roger Hodkinson, pathologist

Tuttle Destroys NASEM’s Report Part 2

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/

The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough! (Part 2)

Carl Tuttle
Hudson, NH, United States
May 21, 2025

Please see the following response to my inquiry previously sent to Dr. Marcia McNutt regarding the National Academies Report “Lyme Infection-Associated Chronic Illnesses”

Original inquiry found here:

The IDSA’s Post Treatment Lyme Disease Syndrome was not good enough!

Response from the National Academies of Sciences:

———- Original Message ———-
From: “Liao, Julie” <JLiao@nas.edu>
To: CARL TUTTLE <runagain@comcast.net>
Date: 05/19/2025 9:47 AM EDT
Subject: Re: Inquiry on National Academies report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses

Good morning,

I am a senior program officer at the National Academies and co-director of the study that produced the report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses. Dr. McNutt shared your message with me, and I am responding on her behalf as a lead staff for the project.

First of all, thank you for your interest in this report and sharing these concerns. The National Academies committee that authored this report is aware of the painful history of disbelief and mistrust in the early days of recognizing and studying persistent symptoms associated with Lyme disease. It is their hope that this report takes the first step toward moving past this history to catalyze actions that prioritize discovery and development of new, effective, safe treatments for people living with these symptoms. To this end, the report explicitly recognizes that Lyme infection-associated chronic illnesses are real, and that these illnesses are debilitating to the health and well-being of many individuals.

Regarding the concern on funding development and use of new antimicrobials, the report recognizes that there may be a multitude of pathogenic mechanisms and calls for exploration of new treatments that can address the different potential pathways leading to these chronic symptoms. This includes pathogen persistence, as well as autoimmunity or other immune dysregulation as a result of Lyme disease.

It is the committee’s hope that new evidence will continue to emerge and advance our collective knowledge and ability to mitigate and one day cure these infection-associated chronic illnesses, including those associated with Lyme disease.

Warm regards,

Julie

Julie Liao, PhD (she/her)
Co-Director
Forum on Microbial Threats
Study on Evidence Base for Lyme-IACI Treatment
Keck 854 | (202) 334-2191

National Academies of Sciences, Engineering, and Medicine
500 Fifth Street, NW
Washington, DC 20001

nationalacademies.org/HMD

Carl Tuttle’s reply:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “Liao, Julie” <JLiao@nas.edu>
Cc: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>, “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/20/2025 10:02 AM EDT
Subject: Re: Inquiry on National Academies report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses

Dear Dr. Liao,

Thank you for responding to my inquiry sent to Dr. Marcia McNutt which is now in the public domain posted as an Update to the Change.org petition; Calling for a Congressional investigation of the CDC, IDSA and ALDF with 106,773 verified signatures.

The optimal treatment for Lyme disease has yet to be determined because the focus early on went directly into developing a vaccine. Here are some examples of how other difficult infections have been handled:

It was once believed that rifampin was curative in treating Brucellosis but when symptoms returned doxycycline was added to the mix and when that too failed a third antibiotic, streptomycin was added to the current treatment regimen. [1] [2]

In 1985 the worldwide incidence of leprosy was 6,000,000. Last year, it was 800,000. The only thing that changed was the addition of rifampin to dapsone in the treatment of the disease. Rifampin was added to dapsone because the M leprae were becoming resistant and it was a new antibiotic at that time.

Treatments for multidrug-resistant tuberculosis have been introduced (bedaquiline and delamanid) with more in the pipeline. [3]

A new treatment for recurrent Clostridium difficile was recently studied (bezlotoxumab) for reducing the risk of a repeat infection. [4]

In contrast, oral amoxicillin or doxycycline remains the treatment of choice for treating Lyme disease for over thirty years regardless if debilitating symptoms return. In 1977 Dr. Allen Steere knew that these antibiotics were not effective for all patients [5] but there has been no change in treatment or research to find more effective ways to eradicate the infection in all stages/forms of disease.

At what point in time do we recognize that we are dealing with an antibiotic resistant/tolerant superbug and focus our research on finding new antimicrobials for this life-altering/life-threatening disease as more of the population becomes severely disabled from inappropriately treated Lyme disease.

From your reply: The report recognizes that there may be a multitude of pathogenic mechanisms and calls for exploration of new treatments that can address the different potential pathways leading to these chronic symptoms. This includes pathogen persistence, as well as autoimmunity or other immune dysregulation as a result of Lyme disease.”

Those of us who have studied the mishandling of Lyme disease believe this is just lip service and the real effort will be spent on expensive treatments for the sick and disabled Lyme community still suffering from chronic Lyme; there’s more profit in providing a lifetime of drugs than on a cure and if a chronic relapsing seronegative disease were identified through the proposed “actions” it would end the current vaccine dream overnight because you cannot prove vaccine efficacy in a disease where we do not know who has or does not have the infection; having a curative approach would also give the public an excuse not to take their vaccine. (Let that sink in)

The Evidence is overwhelming that we have been dealing with an antibiotic resistant/tolerant superbug while the so-called science is (mis)used for legalized gaslighting (Follow the science) The IDSA/CDC have defined the disease (= high costs) away so when patients object; MD’s successfully hide behind their definition and guidelines.

I want to make this crystal clear: Suppressing evidence of antibiotic resistance (as well as ignoring these actions) is a crime and the National Academies has been given detailed notice of this atrocity.
 
Questions:

1. Will the search to find new antibiotics [6] be the research priority?

2. Who will be given responsibility for these studies? (certainly not the same researchers who previously received Lyme funding from the CDC/NIH)

A response to this inquiry is requested.

Carl Tuttle
Independent Researcher
Hudson, NH

Cc: Marcia McNutt, President of the National Academy of Sciences and Chair of the National Research Council
REFERENCES (PLEASE READ!)

1. Chronic Brucellosis and Persistence of Brucella melitensis DNA
https://www.ncbi.nlm.nih.gov/pubmed/?term=Chronic+Brucellosis+and+Persistence+of+Brucella+melitensis+DNA

After acute brucellosis infection, symptoms persist in a minority of patients for more than 1 year. Such patients are defined as having chronic brucellosis. Since no objective laboratory methods exist to confirm the presence of chronic disease, these patients suffer delays in both diagnosis and treatment.

2. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
https://www.ncbi.nlm.nih.gov/pubmed/25246401

The doxycycline-streptomycin-rifampin regimen eliminates Brucella DNA more efficiently than doxycycline-streptomycin, which may result in superior long-term clearance of Brucella.

3. Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs
https://wwwnc.cdc.gov/eid/article/22/3/15-1228_article

4. New C.diff treatment reduces recurrent infections by 40%
https://www.sciencedaily.com/releases/2017/01/170126081724.htm

5. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. (1977)
Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM.

Excerpt:

“The best treatment for this illness is not clear. Some physicians have reported that penicillin or tetracycline results in disappearance of the skin lesion (41,42), but others find antibiotics ineffective. Four of the patients with expanding skin lesions received penicillin but still developed arthritis.”

6. Lyme Disease: Call for a “Manhattan Project” to Combat the Epidemic
Raphael B. Stricker, Lorraine Johnson

Published: January 02, 2014

http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003796

Carl Tuttle’s follow-up message:

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “Liao, Julie” <JLiao@nas.edu>
Cc: “mmcnutt@nas.edu” <mmcnutt@nas.edu>, “vdzau@nas.edu” <vdzau@nas.edu>, “wkearney@nas.edu” <wkearney@nas.edu>, “dmay@nas.edu” <dmay@nas.edu>, “amacdonald@nas.edu” <amacdonald@nas.edu>
Date: 05/21/2025 8:42 AM EDT
Subject: Re: Inquiry on National Academies report, Charting a Path Toward New Treatments for Lyme Infection-Associated Chronic Illnesses

Dr. Liao,

It’s no surprise that the Chair of your committee that published the Consensus Study Report is a vaccinologist. This validates everything I have been reporting about the rush to create a vaccine for Lyme which led to the deliberate mishandling of the disease.

It is obvious that the priority here is still the Lyme vaccine and finding a cure for chronic Lyme is just lip service.

THE GENEVA FOUNDATION

CHAIR OF THE BOARD OF DIRECTORS
 
KENT KESTER, MD, COL (RET.), USA

https://genevausa.org/about/leadership-in-military-medicine/board-of-directors/col-ret-kent-kester/

Kent E. Kester, M.D., is currently Executive Director
Vaccine Research and Development at the Coalition
for Epidemic Preparedness Innovations (CEPI)

Carl Tuttle

_______________

Part 1 here: https://madisonarealymesupportgroup.com/2025/05/16/tuttle-destroys-nasems-lyme-disease-report/

I posted the NASEM Report – ‘new treatments for Lyme Infection-Associated Chronic Illnesses’ here:  https://madisonarealymesupportgroup.com/2025/05/09/charting-a-path-towards-new-treatments-for-chronic-lyme-disease/

Again, here is the old 2014 interview with Willy Burgdorfer where he states research must be started over at square one because the same people have been doing the research and coming up with the same results – nothing!

http:// Approx. 5 Min

Willy Burgdorfer 2014

“Money goes to people that have for the past 30 years produced the same thing.  Nothing.” ~  Willy Burgdorfer

Well, it’s now been a total of more than 40 years and the same thing is being produced, which is nothing.

Yeah – I agree.  Total lip-service to patients. 

It’s all about the ‘vaccine.’